Newport Trust Company
BSX icon

Newport Trust Company’s Boston Scientific BSX Stock Holding History

Newport Trust Company’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,750,135
Closed -$390M – 56
2023
Q4 		$390M Sell
6,750,135
-81,701
-1% -$4.36M 1.04% 16
2023
Q3 		$361M Sell
6,831,836
-25,336
-0.4% -$1.33M 1.11% 16
2023
Q2 		$371M Sell
6,857,172
-60,076
-0.9% -$3.14M 1.08% 17
2023
Q1 		$346M Sell
6,917,248
-32,578
-0.5% -$1.54M 0.96% 17
2022
Q4 		$322M Sell
6,949,826
-327,668
-5% -$14.2M 0.89% 18
2022
Q3 		$282M Sell
7,277,494
-124,323
-2% -$4.99M 0.95% 17
2022
Q2 		$276M Buy
7,401,817
+7,258,993
+5,082% +$295M 0.89% 17
2022
Q1 		$6.33M Sell
142,824
-7,624,326
-98% -$330M 0.02% 48
2021
Q4 		$330M Buy
7,767,150
+108,497
+1% +$4.56M 0.89% 17
2021
Q3 		$332M Sell
7,658,653
-236,086
-3% -$10.4M 0.9% 17
2021
Q2 		$338M Sell
7,894,739
-443,601
-5% -$18.7M 0.85% 16
2021
Q1 		$322M Sell
8,338,340
-431,357
-5% -$16.3M 0.8% 17
2020
Q4 		$315M Buy
8,769,697
+15,864
+0.2% +$572K 0.87% 15
2020
Q3 		$334M Sell
8,753,833
-218,453
-2% -$8.42M 1.17% 12
2020
Q2 		$315M Sell
8,972,286
-222,393
-2% -$8.01M 1.15% 11
2020
Q1 		$300M Sell
9,194,679
-82,291
-0.9% -$3.21M 1.23% 11
2019
Q4 		$420M Sell
9,276,970
-386,692
-4% -$16.2M 1.13% 12
2019
Q3 		$393M Sell
9,663,662
-183,403
-2% -$7.77M 1.05% 13
2019
Q2 		$423M Sell
9,847,065
-375,533
-4% -$14.4M 1.14% 13
2019
Q1 		$392M Sell
10,222,598
-155,626
-1% -$5.94M 1.18% 11
2018
Q4 		$367M Sell
10,378,224
-38,069
-0.4% -$1.38M 1.19% 12
2018
Q3 		$401M Sell
10,416,293
-224,245
-2% -$7.83M 1.11% 12
2018
Q2 		$348M Sell
10,640,538
-80,832
-0.8% -$2.44M 1.01% 12
2018
Q1 		$293M Sell
10,721,370
-394,337
-4% -$10.7M 0.82% 13
2017
Q4 		$276M Buy
+11,115,707
New +$307M 0.77% 16

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Newport Trust Company's BSX Position: Q1 2024 in Review

Newport Trust Company sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 6,750,135 shares — an estimated $390M sold.

Newport Trust Company first reported a position in BSX in Q4 2017 and held it in 25 quarters. The position peaked at $423M in Q2 2019. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Newport Trust Company reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Newport Trust Company sold 6,750,135 Boston Scientific shares in Q1 2024, an estimated $390M.
  • Newport Trust Company first reported a position in Boston Scientific in Q4 2017 and held it in 25 quarters.
  • Newport Trust Company's Boston Scientific position peaked at $423M in Q2 2019.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Newport Trust Company's 13F filing for Q1 2024, filed 15 May 2024.